Wnt signaling and human diseases: what are the therapeutic implications?

[1]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[2]  C. Hartmann.  A Wnt canon orchestrating osteoblastogenesis. , 2006, Trends in cell biology.

[3]  S. O’Rahilly,et al.  WNT10B mutations in human obesity , 2006, Diabetologia.

[4]  Randall T. Moon,et al.  Wnt and calcium signaling: β-Catenin-independent pathways , 2005 .

[5]  W. Birchmeier,et al.  The role of Axin2 in calvarial morphogenesis and craniosynostosis , 2005, Development.

[6]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[7]  Wei Jiang,et al.  Wnt/beta-catenin signaling pathway as a novel cancer drug target. , 2004, Current cancer drug targets.

[8]  Ajamete Kaykas,et al.  WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.

[9]  L. Southam,et al.  Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Nathans,et al.  Frizzled6 controls hair patterning in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  I. Thesleff,et al.  Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. , 2004, American journal of human genetics.

[12]  J. Healey,et al.  Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. , 2004, Cancer research.

[13]  Michael J Parker,et al.  Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. , 2004, American journal of human genetics.

[14]  E. Fuchs,et al.  Socializing with the Neighbors Stem Cells and Their Niche , 2004, Cell.

[15]  Chengfeng Zhao,et al.  Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family. , 2004, American journal of human genetics.

[16]  R. White,et al.  Targeted degradation of β-catenin by chimeric F-box fusion proteins , 2004 .

[17]  H. Macdonald,et al.  β-Catenin Is Dispensable for Hematopoiesis and Lymphopoiesis , 2004, The Journal of experimental medicine.

[18]  F. Zhan,et al.  The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. , 2003, The New England journal of medicine.

[19]  H. Ujike,et al.  The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia , 2003, Neuroscience Letters.

[20]  T. Couffinhal,et al.  Reduction of Infarct Size and Prevention of Cardiac Rupture in Transgenic Mice Overexpressing FrzA , 2003, Circulation.

[21]  A. Bradley,et al.  Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. , 2003, Cancer cell.

[22]  Haiyang Huang,et al.  Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.

[23]  S. Ishikawa,et al.  Eradication of pathogenic β-catenin by Skp1/Cullin/F box ubiquitination machinery , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Varmus,et al.  A protein knockdown strategy to study the function of β-catenin in tumorigenesis , 2003, BMC Molecular Biology.

[25]  E. Vilain,et al.  Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/β-catenin synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Michael D. Schneider,et al.  Sizing up the heart: development redux in disease. , 2003, Genes & development.

[27]  A. Perantoni.  Renal development: perspectives on a Wnt-dependent process. , 2003, Seminars in cell & developmental biology.

[28]  B. Alman,et al.  Beta-catenin expression in Dupuytren's disease: potential role for cell–matrix interactions in modulating beta-catenin levels in vivo and in vitro , 2003, Oncogene.

[29]  K Oshima,et al.  Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity , 2003, The British journal of ophthalmology.

[30]  Andrea Caricasole,et al.  The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease? , 2003, Trends in pharmacological sciences.

[31]  J. Szatkowski,et al.  Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. , 2003, Cancer letters.

[32]  R. Surabhi,et al.  Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  L. Hofbauer,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[34]  M. R. Islam,et al.  The Polycystic Kidney Disease-1 Promoter Is a Target of the β-Catenin/T-cell Factor Pathway* , 2002, The Journal of Biological Chemistry.

[35]  M. Hayden,et al.  Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy , 2002, Nature Genetics.

[36]  M. Daemen,et al.  The wnt-frizzled cascade in cardiovascular disease. , 2002, Cardiovascular research.

[37]  M. Oshimura,et al.  Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin. , 2002, Cancer research.

[38]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[39]  Hans Clevers,et al.  β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Belmaker,et al.  GSK-3 and the neurodevelopmental hypothesis of schizophrenia , 2002, European Neuropsychopharmacology.

[41]  Simon Lovestone,et al.  Alzheimer's disease – do tauists and baptists finally shake hands? , 2002, Trends in Neurosciences.

[42]  M. Sakaguchi,et al.  Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. , 2001, Biochemical and biophysical research communications.

[43]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[44]  W. Weis,et al.  β-catenin: molecular plasticity and drug design , 2001 .

[45]  Bert Vogelstein,et al.  Combinatorial chemoprevention of intestinal neoplasia , 2000, Nature Medicine.

[46]  C. Hartmann,et al.  Dual roles of Wnt signaling during chondrogenesis in the chicken limb. , 2000, Development.

[47]  K. Kinzler,et al.  The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. , 2000, Cancer research.

[48]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[49]  G. Cossu,et al.  Wnt signaling and the activation of myogenesis in mammals , 1999, The EMBO journal.

[50]  P. Morin,et al.  β‐catenin signaling and cancer , 1999 .

[51]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[52]  Tsuyoshi Miyaoka,et al.  Increased expression of Wnt-1 in schizophrenic brains , 1999, Schizophrenia Research.

[53]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[54]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[55]  Hans Clevers,et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 , 1998, Nature Genetics.

[56]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[57]  E. Fuchs,et al.  Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. , 1995, Genes & development.

[58]  I Fariñas,et al.  Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. , 1994, Genes & development.

[59]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[60]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[61]  Randall T Moon,et al.  Wnt and calcium signaling: beta-catenin-independent pathways. , 2005, Cell calcium.

[62]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. , 2004, Cancer cell.

[63]  Raymond L. White,et al.  Targeted degradation of beta-catenin by chimeric F-box fusion proteins. , 2004, Biochemical and biophysical research communications.

[64]  Randall T Moon,et al.  WNT and beta-catenin signalling: diseases and therapies. , 2004, Nature reviews. Genetics.

[65]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex , 2004 .

[66]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[67]  W. Weis,et al.  beta-catenin: molecular plasticity and drug design. , 2001, Trends in biochemical sciences.

[68]  K. Kinzler,et al.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. , 1999, Cell.

[69]  P. Polakis.  The oncogenic activation of beta-catenin. , 1999, Current opinion in genetics & development.

[70]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[71]  P. Morin,et al.  beta-catenin signaling and cancer. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[72]  D. J. Van Den Berg,et al.  Role of members of the Wnt gene family in human hematopoiesis. , 1998, Blood.

[73]  H Clevers,et al.  Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. , 1998, Immunity.

[74]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.